Optimizing seed quality with Cold Plasma.
Non-Thermal Plasma (NTP) — seed treatment for seed companies and seed processors. We improve seed quality, control seed-borne pathogens, and lift vigor. Dry, non-GMO, no residue.
Non-Thermal Plasma (NTP) — seed treatment for seed companies and seed processors. We improve seed quality, control seed-borne pathogens, and lift vigor. Dry, non-GMO, no residue.
The seed industry faces a compounding crisis: falling performance, rising chemical dependency, and tightening regulations.
Millions of seeds fail to sprout or emerge late, leading to uneven stands and lost revenue for producers worldwide.
Agricultural margins are tightening. When seeds fail, it's a direct financial loss for producers—compounded by the cost of replanting.
The industry is trapped between yield demands and increasing regulatory pressure to eliminate pesticides.
After 15+ years of R&D, we have successfully scaled cold plasma — also known as Non-Thermal Plasma (NTP) — from laboratory proof-of-concept to industrial reality. Our cold plasma process uses controlled electrical discharges to create a highly efficient chemical environment with low activation energy, stimulating the seed's natural biological potential. Every module is built to drop into the lines seed companies and seed processors already run.
Our treatment works with the seed's existing biology. No genetic modification—just unlocking the natural potential already within.
Zero chemical residue left on the treated material. A completely clean process that leaves nothing behind but improved performance.
No water, no solvents, no drying steps. Our plasma process operates entirely dry, simplifying logistics and reducing operational costs.
Built for seed companies and seed processors. Each cold plasma solution targets a critical stage in seed performance, from initial vigor to final harvest.
Focus: Speed, Uniformity, and Recovery
Rapidly improves germination energy and restores aged or substandard lots to marketable standards.
Validation results in days, offering immediate inventory gains and operational continuity.
Focus: Bio-protection and Defense
Achieved a significant reduction in seed-borne pathogens like Diaporthe/Phomopsis.
Targeted elimination of harmful surface and internal pathogens without damaging the seed.
Focus: Harvest Maximization
Our treatment prevents the "oxidative burst" triggered by fungal infections, resulting in plants with significantly lower oxidative stress levels.
Consistently outperforms traditional fungicide treatments in growth traits and final harvest output.
We run pilots with seed companies and seed processors, with validation results in days.
World-class investors and accelerators that believe in the future of sustainable agriculture.
Coverage of our cold plasma seed treatment across agriculture and technology media, and the programmes backing the company.
Landscape feature on Argentine agtech in which Sylvarum is profiled alongside the country's leading startups. Guadalupe Murga explains how plasma discharges improve germination power, vigor and emergence uniformity without modifying genetics or adding chemicals. Reports seven employees, pilots underway, over US$1M raised and a 2027 commercial launch target.
Sylvarum is selected for RootCamp's eighth cohort — nine startups from Germany, France, Slovakia, Argentina and the United States — described as developing "non-thermal plasma and electrostimulation technologies to enhance seed performance and quality." The selection marks the company's formal entry into the European market, with Demo Day set for 26 November in Hannover.
By Elaine Watson
Video interview with Guadalupe Murga, and the most substantial English-language coverage to date. Sylvarum says it operates the world's largest plasma reactor for seed treatment, backed by five seasons of field validation across corn, sunflower, soybean, wheat and barley. Covers the fee-per-ton commercial model, seven active pilots with a target of ten, and operations spanning Latin America, Europe and the US.
The founding and pivot story: how investor feedback during a San Francisco fundraise redirected Sylvarum from hydroponics in Tucumán to broadacre agriculture. Traces the technology to over a decade of public research at UTN, FAUBA and CONICET, and announces the partnership with LS Electromecánica to install equipment across Argentina's 100+ seed processing plants.
Coverage of Sylvarum's US$850,000 round from national and international investors, with confirmed participation from Inventure, Aapresid's venture fund. Cites a 60% reduction in germination latency, up to US$800,000 in annual savings per processing plant, recovery of 10% of production currently discarded for germination problems, and treatment effects persisting 6–8 months.
Technology feature on the CONICET origins of Sylvarum's plasma treatment, with Dr. Karina Balestrasse (FAUBA) and Dr. Leandro Prevosto (UTN Venado Tuerto). Reports trial results in soybean, corn and wheat showing improved vigor and germination, significant yield increases and potential agrochemical reduction.
Sylvarum took part in the EU–Argentina AgTech 4.0 congress and business matchmaking session in Buenos Aires, represented by CEO Guadalupe Murga, seeking pilot partnerships under the programme's goal of expanding commercial and investment ties between the EU and Argentina.
Sylvarum was selected for the AgriFood stream at CDL-Rockies. CDL's profile describes technology that "promotes faster and more uniform sprouting, while effectively eliminating pathogens and ensuring healthier crop growth," shortening growth cycles and increasing resilience to environmental stress.
Whether you're looking to run a pilot, explore a partnership, or simply learn more about our technology — we'd love to hear from you.
Location
Buenos Aires, Argentina.